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Abstract
Increases in cellular Reactive Oxygen Species (ROS) concentration with age have been observed repeatedly in mammalian
tissues. Concomitant increases in the proportion of replicatively senescent cells in ageing mammalian tissues have also been
observed. Populations of mitotic human fibroblasts cultured in vitro, undergoing transition from proliferation competence
to replicative senescence are useful models of ageing human tissues. Similar exponential increases in ROS with age have
been observed in this model system. Tracking individual cells in dividing populations is difficult, and so the vast majority of
observations have been cross-sectional, at the population level, rather than longitudinal observations of individual
cells. One possible explanation for these observations is an exponential increase in ROS in individual fibroblasts with time
(e.g. resulting from a vicious cycle between cellular ROS and damage). However, we demonstrate an alternative, simple
hypothesis, equally consistent with these observations which does not depend on any gradual increase in ROS
concentration: the Stochastic Step Model of Replicative Senescence (SSMRS). We also demonstrate that, consistent with the
SSMRS, neither proliferation-competent human fibroblasts of any age, nor populations of hTERT overexpressing human
fibroblasts passaged beyond the Hayflick limit, display high ROS concentrations. We conclude that longitudinal studies of
single cells and their lineages are now required for testing hypotheses about roles and mechanisms of ROS increase during
replicative senescence.
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Introduction
Since the proposal of the Free Radical Theory of Ageing [1],
reports linking Reactive Oxygen Species (ROS) generation,
mitochondrial function and the ageing process have been
accumulating [2]. However, despite this wealth of mostly
correlative evidence, we are still far from understanding the role
of ROS in ageing. Recent experimental observations have
reopened the question of the role of ROS in the ageing process;
observations of ROS concentrations and fraction of senescent cells
after genetic interventions affecting both mitochondrial function
and oxidative stress in animal models have led to conflicting
conclusions [3,4,5,6].
The role of ROS in replicative senescence, the permanent arrest
of the cell cycle in normally proliferating cells such as fibroblasts, is
not well understood.
Early evidence suggested that cells which were continuously
passaged in vitro until senescence underwent time-dependent
accumulation of damage. Senescent cell populations were found
to have increased production of ROS [7,8] and to accumulate
oxidation products such as protein carbonyls, protein oxidative
modifications [9], lipofuscin [10,11] and DNA damage [8].
Mitochondria, the main sources of ROS, have been implicated
in the process, since senescent cells were found to have impaired
metabolism [8,12] and damage to mitochondria [8].
More importantly, interventions which decreased ROS in cells
were found to impact on replicative senescence. Exposure to low
ambient oxygen concentrations [13,14], free radical scavengers
[15,16], overexpression of antioxidant enzymes [17] and mild,
chronic mitochondrial uncoupling [8] have been shown to
decelerate telomere shortening and to extend replicative lifespan
of cells in culture. These data are all consistent with the hypothesis
that one of the major contributing factors to replicative senescence
is time-dependent accumulation of oxidative damage.
However, evidence has emerged suggesting a novel role for
ROS in replicative senescence. It has been reported that the
activation of key players in the senescence pathway contributes to
ROS generation, without cells undergoing time-dependent
damage accumulation. Signalling via Ras [18], p53 [19], p21
[20,21] and p16 [22] have been shown to induce ROS generation,
contributing to the initiation of the senescent phenotype. These
observations could be explained by ROS acting as signalling
molecules and therefore as outcomes of a tightly regulated process
signalling for replicative senescence [23,24].
However, one question remains: how can we reconcile data
suggesting a gradual ROS increase preceding induction of
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senescence with the observation that ROS increases in a rapid,
step-wise manner as a consequence of signalling events, similar to
apoptosis?
Cross-sectional observations of ROS and ROS-derived prod-
ucts in populations of cells at different Population Doublings (PDs)
are consistent with a hypothesis of a gradual, cumulative increase
in ROS generation. However, cell populations are highly
heterogeneous [25] and cells bearing senescent markers can be
found even in populations of young cells [8,26]. Here we examine
an alternative biological hypothesis to gradual cellular-level
changes in phenotype: that the change in ROS observed at the
population-level is a mere consequence of a time-dependent
increase in the fraction of senescent cells in the population, with
individual cells undergoing discrete, asynchronous, stochastic
increases in ROS levels. In order to have a mechanistic
understanding of the role of ROS in replicative senescence, we
must be able to distinguish between these two very different
hypotheses.
To test our alternative hypothesis we developed a Stochastic
Step Model of Replicative Senescence, describing discrete,
stochastic changes in cellular ROS levels upon transition from
proliferation to replicative senescence. We present a dataset
describing increasing rates of Mitochondrial ROS production with
increasing PD in populations of human MRC5 fibroblasts,
repeatedly passaged until they reach replicative senescence. By
comparing experimental observations with model predictions we
demonstrate that the gradual, continuous ROS dynamics observed
in these populations could also be explained by stochastic, discrete
transitions between proliferative and senescent states at the cellular
level without any recourse to gradual accumulation of damage in
individual cells. In other words, the increase of ROS observed
during long-term cultivation of primary cells could be a
consequence of the senescent phenotype rather than a gradual
accumulation of damage as earlier proposed. We demonstrate
that, in mixed populations of senescent and proliferating cells,
those cells which are not expressing senescence markers (Ki67+ve
with less than 5 DNA damage foci [26]) have significantly lower
rates of ROS production than those which do not. We also present
a second dataset demonstrating that cellular ROS production rates
remain constant in proliferation-competent cells (MRC5 fibro-
blasts overexpressing hTERT) passaged 90 PDs beyond the
Hayflick limit, which is not consistent with a hypothesis of gradual
accumulation of damage in cells, but is consistent with our
alternative hypothesis and our model.
Materials and Methods
A step model of changing phenotypes in an ageing cell
population
We assume that cellular phenotypes change in a discrete fashion
during the transition from proliferation-competence to senescence
(see Figure 1A). The size, morphology, division rate or oxidative
state of cells could change in this fashion for example. Figure 1A
illustrates a proliferating population of cells with a relatively
narrow distribution of phenotypes undergoing stochastic step
transitions to a much broader distribution of phenotypes
associated with replicative senescence. The population doubling
number at which this transition takes place is also sampled from a
distribution, representing variability in the actual age of individual
cells as well as variability in the age at which they undergo
transition. These three distributions capture biological heteroge-
neity in states and in timings which are not actively coordinated.
Here we consider a general phenotype of value Q. We describe
the expected Q for a mixed population of senescent and
proliferation-competent cells: QMix. We assume that there are
two underlying Q distributions corresponding to sub-populations of
proliferation-competent and replicatively senescent cells, with an
expected value for proliferation-competent cells: QP, and a distinct
expected value for replicatively senescent cells: QS. In this analysis
we estimate these two parameters from experimental observations
of populations of cells which we assume to be 100% proliferating
and 100% senescent respectively.
We can then describe QMix as a function of the fraction of
proliferating cells (p) and the fraction of senescent cells (s):
Figure 1. A simple stochastic step model explains Reactive Oxygen Species production in cell populations undergoing senescence
and in immortal cells. A) Hypothesis: Schematic representation of a step increase in phenotype for 100 cells. Each coloured trace represents one
cell as it undergoes transition from proliferation-competence to senescence. Phenotype for each cell in the proliferating state is drawn from a
relatively narrow distribution; whereas the phenotype of senescent cells is drawn from a broader distribution, with a higher expected value. All
phenotype transitions are strictly non-decreasing. With increasing PD a higher proportion of cells in the population become senescent. B) Normalised,
mean MitoSOX fluorescence measured by flow cytometry varies with PD in MRC5 fibroblasts cultivated until senescence (blue points). Normalised
mean mitochondrial mass in a distinct population of the same cell type varies with PD (red points). Linear interpolation approximations to these
curves were constructed (red and blue lines) and MitoSOX/mitochondrial mass estimated (green line); C) Kinetics of interpolated (solid lines)
normalised MitoSOX fluorescence (blue), normalised mitochondrial mass fluorescence (red) and MitoSOX/mitochondrial mass ratio (green) are
compared with mean population estimates from a stochastic step model (dashed lines). Stochastic step model parameters are estimated from the
distributions for a wholly proliferative population (PD27) and for a wholly senescent population (PD47).
doi:10.1371/journal.pone.0032117.g001
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QMix~pQpzsQs ð1Þ
We assume that there are only senescent and proliferating cells in
the population, therefore:
pzs~1 ð2Þ
Further, we assume that the senescent phenotype value is greater
than that of the proliferating phenotype:
Qs~aQp ð3Þ
a§1
Substituting Eqs. 3 and 2 into Eq. 1 gives:
QMix~(az1{s)Qp ð4Þ
The fraction of senescent cells found in a population can be
estimated as a function of population doublings: s(PD), from an
observed growth curve for that population as described previously
[26], or by observing the change in fraction of cells in a population
expressing biomarkers for senescence with PD. The former
method has two advantages over the latter: it provides an estimate
of senescent fraction consistent with the most fundamental
definition of replicative senesence (an irreversible loss of cell
division potential) as well as providing an estimate of uncertainty
in senescent cell fraction for all PDs. We therefore use the growth
curve method for estimating senescent cell fraction dynamics in
this analysis. The analysis presented previously was carried out on
the same cell line we investigate here [26]. We constructed a linear
interpolation function s(PD) from hundreds of parametric
estimates generated previously between PD25 and PD47 and
constructed an estimate for QMix as a function of population
doubling number:
QMix(PD)~(az1{s(PD))QP ð5Þ
An equivalent expression can be derived for the variance of Q
subject to assumptions about the covariance between phenotype
distributions for proliferating and senescent cells.
We selected MitoSOX/mitochondrial mass ratio (MSMM) rate
as our phenotype Q, expressing it as a function of population
doubling number as in Eq. 5. To compare model predictions with
observed data, we estimated QP as the mean normalised ROS
production rate observed in a population of cells which are known
to be .95% proliferating (e.g. a population with low doubling
number (,30), Figures 1B, 1C). a is estimated as QS/QP, where QS
is similarly estimated from a population of cells known to be
,100% senescent (e.g. a population with doubling number close
to the Hayflick limit which has stopped dividing). Model
predictions for intermediate, mixed populations were plotted and
compared with experimental observations (Fig. 1C) using the R
statistical software package [27].
Phenotype distribution analysis
We fitted Gamma distributions to microscopically observed
MitoSOX levels per cell from a proliferating cell population, and
from a wholly senescent population (Figure S1A). A mixed
population of 50% proliferating and 50% senescent cells consistent
with the stochastic step model was simulated. The simulated
mixture was tested for bimodality with 500 samples (representing a
practical, experimentally observable population size) using Harti-
gan’s dip test [28] as implemented in the diptest package in R.
We performed a similar analysis on samples from WI-38 cell
volume distributions observed by Mitsui & Schneider [29]. We
digitised the observed cell volume frequency distributions for
proliferating cells (PD19) and fully senescent cells (PD45) using
GraphExtract2.5 for Windows. We converted these to probability
density distributions and sampled from these repeatedly to
simulate mixed populations of senescent and proliferating cells
consistent with the step model and tested simulated mixed
populations for bimodality as above (Figure S1B).
We also investigated whether predicted population distribution
changes could be adequately predicted by the SSMRS. To do this,
we considered MitoSOX fluorescence alone as our phenotype Q.
Measurements of thousands of cells were made by fluorescence-
activated cell sorting of populations of our MRC5 fibroblasts,
capturing distributions of MitoSOX fluorescence per cell at PD38,
PD41, PD44, PD45 and PD46. We assumed that all cells at PD38
were proliferation competent and used this distribution as QP. We
can see from Figure S2F that about 90% of cells were proliferation
competent at that PD and therefore this assumption is reasonable.
We also assumed that the observed population at PD46 was
completely senescent, and therefore used this distribution as QS.
Again, we can see from Figure S2F that this is reasonable. We also
assumed that the uncertainty in senescent fraction as a function of
PD (s(PD), Fig. S2 F) which was previously estimated for these cells
[26] comes from stochasticity in the timing of cellular transition
from proliferation competence to replicative senescence. For
intermediate PDs (PD41, PD44 and PD45) we simulated 10,000
cells, assigning a probability that cells were proliferating or
senescent, based on the uncertainty in s(PD), Fig. S2 E. We then
randomly classified each simulated cell as proliferating or
senescent, weighted by those probabilities. For each cell classified
as proliferating, we sampled (with replacing) a MitoSOX
fluorescence observation from QP. Similarly, for each cell classified
as senescent, we sampled a MitoSOX fluorescence observation
from QS. We then plotted the simulated mixed populations
alongside observed intermediate distributions and observed good
agreement (simulated fluorescence was greater than observed
fluorescence for only 45%, 51% and 53% of the 10,000 simulated
samples at intermediate PDs: PD41, PD44 and PD45 respectively).
Cell culture
Human embryonic lung MRC5 fibroblasts were obtained from
ECACC (Salisbury, UK) and cultured until reaching senescence.
Cells were considered senescent when positive for Sen-b-Gal and
negative for proliferating markers (BrdU and Ki67).
MRC5 cells were transfected retro-virally at PD30 with the
human catalytic subunit (hTERT) of the enzyme telomerase as
described in [30]. These transfected cells were cytogenetically
tested at PD100. No cytogenetic abnormalities were observed.
Mouse ear fibroblasts (MEFs) were obtained from C57Bl6 wild-
type mice at 3 months of age.
All cells were grown in DMEM supplemented with 10% foetal
calf serum, 2 mM glutamine and 1% pen/strept under controlled
conditions (air plus 5% CO2) in a 3-gas incubator. Cells were
always passaged before confluency.
Ethics statement
All work complied with the guiding principles for the care and
use of laboratory animals. The project was approved by the
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Faculty of Medical Sciences Ethical Review Committee, New-
castle University. Project licence number 60/3864.
MitoSOX staining and Immunofluorescence
Flow cytometric analysis of MitoSOX and NAO fluorescence
was performed as described in [8].
Cells grown on coverslips were stained with 5 mM MitoSOX
(Invitrogen) for 10 min at 37uC. Cells were washed with PBS and
fixed with 2% paraformaldehyde for 5 min.
Immunofluorescence was then conducted as described in [8].
Anti-cH2A.X mouse monoclonal (Upstate), Anti-Ki-67 Rabbit
polyclonal (ab15580 Abcam) were used.
All fluorescence microscopy was performed using a Leica
DM5500B fluorescence microscope, using a 4061.3 NA oil
objective. Fluorescent images were always taken under identical
excitation and emission condition. MitoSOX intensity was
quantified using ImageJ (http://rsb.info.nih.gov/ij/). For each
experiment a minimum of 50 cells were analysed.
Results
A simple stochastic step-model explains the rate of ROS
production in a population of cells undergoing
replicative senescence
We cultured MRC5 fibroblasts from PD18 until replicative
senescence (PD47) and measured average population MitoSOX
fluorescence by flow cytometry. We observed an exponential
increase in population MitoSOX fluorescence with PD (Figure 1B).
A proportion of this increase is due to increases in mass of
mitochondria per cell during the transition from proliferation to
senescence [31], and so we also measured mitochondrial mass by
NAO fluorescence in a separate sub-population of the same cell
line. To estimate MitoSOX/mitochondrial mass ratio (MSMM) we
approximated each of the fluorescence time courses from distinct,
replicate cell populations by linearly interpolating between
observations (Figure 1B & C), normalising each by their value at
the earliest common PD (PD27), giving estimates of fluorescence
kinetics across the full range of observed PDs. We constructed
MSMM from separately normalised MitoSOX and mitochondrial
mass observations. We modelled MSMM dynamics with the
stochastic step model described above, setting QP=MSMM
observed at PD27 and QS=MSMM observed at PD47. We repeated
this analysis for normalised MitoSOX and mitochondrial mass
separately. Modelled population mean MitoSOX fluorescence,
mitochondrial mass and MSMM increased in an approximately
exponential manner with PD (Figure 1B). Calibrating model
parameters with observations from young (proliferative) cells and
old (wholly senescent) cell populations, and using an estimate of
the rate of increase of senescent cell fraction with PD [26], model
predictions for all three of these phenotypes were validated by
comparison with experimental observations at intermediate PDs
(Fig. 1C). Experimental observations were adequately described by
the stochastic step model: Pearson’s correlation coefficient between
observed and simulated mean MSMM were .0.93 for all three
comparisons.
MitoSOX staining distributions measured by flow cytometry as
cells reach senescence were unimodal at any given analysed time
point (Fig. S2 A–D). Intuitively the absence of a bimodal
distribution in a mixed population of both young cells (with low
MitoSOX staining) and senescent cells (with high MitoSOX
staining) could seem inconsistent with a step-wise increase in ROS
and might be suggest that cells with intermediary levels of ROS
exist at any given time-point before 100% of the population
undergoes senescence.
To test if this observation was consistent with our step-model we
simulated MitoSOX distributions of a population containing a
mixture of proliferating (50%) and senescent (50%) cells by mixing
experimental observations from cell populations containing
predominantly proliferating cells (PD20) and from populations of
senescent cells (PD47) and analysing the resultant mixture
distributions.
The simulation revealed that such populations still showed a
unimodal MitoSOX distribution (Figure S1A). This is likely to be a
consequence of senescent populations being more heterogeneous
than proliferating ones (standard deviation more than 8 times
greater), greater even than the increase expected from the increase
in distribution mean (less than 7 times greater).
An independent analysis using data on cell volume distributions
from another study [29] confirms that simulated distributions of
mixed populations of senescent and proliferating cells are entirely
consistent with an unimodal distribution (Figure S1B).
We also found that changes in the shape of population
phenotype distribution could be adequately predicted by the
SSMRS (Figure S2).
Ki67 negative cells containing more than 5 cH2A.X foci
have significantly higher MitoSOX levels than Ki67
positive cells
Previously we have shown that the absence of activity of the
proliferation marker Ki67 combined with high density of DNA
damage foci (.5 foci/nucleus) was a quantitative marker of
senescence in both human and mouse fibroblasts [26]. We have
now developed an experimental method which allows simulta-
neous assessment of MitoSOX fluorescence together with
immunofluorescence against Ki67 and cH2A.X.
Firstly, we performed MitoSOX staining on MRC5 fibroblasts
at various PDs (e.g. Fig. 2A) and quantified fluorescence intensity
per cell (Figs. 2B & C). We found similar results to the ones found
by flow cytometry, confirming that we can reliably quantify
MitoSOX fluorescence using microscope images (Figure 2D).
Secondly, we combined MitoSOX staining and immunofluo-
rescence against Ki67 and cH2A.X (Figure 2A–C). We observed
that MitoSOX intensity remained constant with PD in Ki67
positive cells (Figure 2C). In the low percentage of Ki672 cells
with more than 5 cH2A.X foci which we found in pre-senescent
cultures, MitoSOX fluorescence levels were substantially higher
than in Ki67 positive cells or in Ki672 cells with ,5 cH2A.X foci
(Figure 2C).
The same exponential increase in MitoSOX fluorescence,
consistent with the step model, was confirmed in fibroblasts
isolated from C57Bl6 wild-type mice ears. During the proliferative
stage, no differences in MitoSOX staining were observed. Once
the fibroblasts reached senescence a two-fold increase in MitoSOX
fluorescence was observed (Figure 2E).
hTERT overexpressing MRC5 cells do not undergo an
exponential increase in ROS production rate despite
being cultured throughout 140 population doublings
We ectopically overexpressed hTERT in human MRC5
fibroblasts at PD30 [30]. The resulting cells displayed high levels
of telomerase activity, stabilized telomere length and greatly
extended replicative lifespan [30]. We measured MitoSOX
fluorescence systematically and found no significant changes
occurring over a wide range of PDs (Figure 3). A low, constant
level of MitoSOX, approximately equal to that observed in non-
transfected MRC5 fibroblasts, is not consistent with damage
Step Model Explains ROS in Ageing Cell Populations
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accumulation with time leading to increased ROS but is entirely
consistent with the stochastic step-model which we present here.
Discussion
During in vitro studies, cross-sectional samples of passaged cell
populations are taken after various population doublings. Cell age
is typically classified on a population-level by PD, indicating the
mean number of divisions undergone since an initial progenitor
cell. However, it has been extensively described that cell
populations are heterogeneous in terms of their division potential,
even in clonal populations derived from single progenitors [25].
The heterogeneity in division potential, which is inherently
stochastic, is evident from the presence of cells bearing senescent
markers even in young populations [26].
As cells reach senescence, a progressive increase in ROS
generation can be observed [7,8,12]. Most literature has suggested
oxygen toxicity as a major contributor to ROS generation during
in vitro senescence. The inability of cells to deal with atmospheric
oxygen concentration has been proposed as a major contributor to
the time-dependent accumulation of several types of damage, such
as lipofuscin, mitochondrial dysfunction, protein oxidation and
DNA damage [11,32,33].
Recently, it has been demonstrated that ROS were necessary
for the long-term maintenance of DDR and for the stability of
growth arrest which characterises the senescent phenotype [21]. It
is therefore possible that prolonged in vitro cultivation does not lead
to time-dependent ROS generation in proliferation-competent
cells and that the majority of ROS generated is a consequence of
processes which occur secondarily to cells becoming irreversibly
arrested.
Our observations are consistent with such a concept. Firstly,
proliferating cells (whether immortalised, and grown for extended
passages beyond the Hayflick limit, or simply positive for
proliferating marker Ki67) appear to be unchanged in terms of
time-dependent ROS accumulation. Secondly, a model simulating
a step-like ROS increase in senescent cells is able to explain
population kinetics of ROS generation during serial cultivation of
populations of human fibroblasts.
Other factors linked to senescence will also contribute to this
ROS increase. The fact that senescent cells are larger and contain
more mitochondria [31] will contribute to the increase in
MitoSOX fluorescence observed in senescent cells. Nonetheless,
we have confirmed that the increase in MitoSOX fluorescence is
still significantly higher in senescence when we normalise either for
mitochondrial mass or cell size.
Although our model can explain the major changes occurring
during cultivation, we cannot invalidate damage accumulation as a
contributing factor to the induction of senescence, since it has been
well demonstrated that interventions reducing oxidative damage
Figure 2. Ki67 negative cells containing more than 5 cH2A.X foci have significantly higher MitoSOX levels than Ki67 positive cells.
A) Representative fluorescent images of YOUNG (PD30) and senescent (SEN, PD47) cells stained with MitoSOX followed by immunostaining against
Ki67 and cH2A.X. MitoSOX staining (red); Ki67 (yellow); cH2A.X (green); DAPI (blue). B) Boxplots showing MitoSOX intensity in Ki67+ fibroblasts at 3
different PDs (,50 cells per condition were quantified) C) MitoSOX intensity in Ki67+, Ki672,5 cH2A.X foci and Ki672.5 cH2A.X foci MRC5
fibroblasts (,50 cells per condition were quantified). Asterisk indicates significance when comparing Ki672.5 foci with the two other groups by 2-
Way ANOVA; D) Comparison between MitoSOX fluorescence kinetics obtained by flow cytometry and microscopy in human fibroblasts; E) MitoSOX
data (grey area) and growth curve (red circles) of mouse ear fibroblasts grown under 20% oxygen (data are from 3 independent mice).
doi:10.1371/journal.pone.0032117.g002
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can extend replicative lifespan and reduce fractions of cells bearing
senescent markers [34]. One possibility is that damage does
accumulate but at lower levels than we can detect using the
available assays. In this case, our data suggest that mitochondrial
ROS could be a useful marker of senescence.
The model we present here is distinct from the hypothesis that
ROS increase is a consequence of time-dependent damage
accumulation in proliferating cultured fibroblasts. While both
hypotheses are consistent with cross-sectional, population average
experimental observations from fibroblasts undergoing the transition
to senescence, new experimental observations presented here,
particularly ROS immutability in proliferation-competent cells in
old cell populations and in hTERT-overexpressing cells dividing well
past the Hayflick limit, strongly support our stochastic step model.
Further experimental dissection of these alternate hypotheses
might greatly improve our understanding of the ageing process since
cells expressing various senescence markers, including DNA damage
foci, do accumulate in human [35], primate [36,37] and mouse
[38,39] tissues with advancing age. Moreover, in mice tissues, age-
dependent increase in fraction of senescent cells has been shown to be
temporally and spatially associated with markers of oxidative stress
[38,40]. In the livers of ageing mice, around 20% of hepatocytes are
positive for cH2A.X DNA damage foci which have been shown to
correlate with the Sen-b-Gal senescence biomarker. Even higher
frequencies of cH2A.X positive cells have been found in small
intestinal crypts, lungs and spleens of old mice [38].
The association of senescence with a sudden, large increase in
ROS production might be responsible for the negative impact of
senescent cells on their tissue environment and contribute to
organismal ageing. However, one needs to be cautious when
extrapolating results from in vitro models to the in vivo context, as
further experiments need to be conducted to ascertain the role of
ROS produced by senescent cells in vivo.
Nonetheless, supporting this hypothesis is the finding that mice
with critically short telomeres, the late generation TERC2/2,
exhibit increased fraction of senescent cells [41], as well as
increased ROS [21] in tissues. Moreover, deletion of CDKN1A,
one of the downstream effectors of cellular senescence, is able to
reduce ROS production and extend lifespan in late generation
TERC2/2 mice [21,42].
To fully discriminate between a hypothesis of gradual
accumulation of ROS during senescence and our alternate
hypothesis of discrete stochastic changes in heterogeneous
populations, and to develop our understanding of the causes and
consequences of replicative senescence, longitudinal studies of
single cells and their lineages are now required.
Supporting Information
Figure S1 The stochastic step model of replicative
senescence predicts unimodal phenotype distributions for
mixed populations of cells undergoing transition to senes-
cence. A) MitoSOX fluorescence per cell quantified from
microscopy images for a proliferating population (PD20, red
histogram) and a wholly senescent population (PD47, blue
histogram) of MRC5 fibroblasts. MitoSOX levels for both
populations were modelled as following gamma distributions (red
and blue curves respectively). A mixed population of 500 cells
(50% senescent) was simulated by sampling from the two
distribution models and the kernel density estimate for the mixed
population is shown here (black dashed line). 500 is a reasonable
emulation of a cell population which can practically be observed.
B) Frequency distributions from [29] describing the volume of WI-
38 cells (human foetal lung fibroblasts) at PD19 and PD45 were
digitised and replotted here after conversion to probability density
distributions (red and blue solid lines respectively). Assuming the
step model describes the change in cell volume in these cells,
simulating mixed populations of proliferating and senescent cells
by weighted random sampling from distributions from PD19 and
PD45 does not produce bimodal cell volume distributions (as an
example, a 50:50 mixture of senescent and proliferating cells is
simulated, dashed black curve).
(EPS)
Figure S2 The stochastic step model of replicative
senesence predicts the shape of MitoSOX distributions
for mixed populations of cells undergoing transition to
senescence. A) MitoSOX fluorescence density distribution
obtained by flow cytometry of MRC5 fibroblasts at PD37.9.
Approximately 90% of cells at this PD were proliferation
competent (see panel F); B–D) For PD41.1 (B) PD44.1 (C) and
PD45.1 (D) we simulated mixtures of 10,000 cells, assigning a
probability that cells were proliferating or senescent by analysis of
cell growth curve (see panel F) and randomly sampling from
distributions at PD37.9 and PD46.4 depending on whether cells
were classified as proliferating or senesecent. Density distributions
show that the simulated mixed populations (red line) and
experimental data obtained by flow cytometry (black line) are in
good agreement; E) MitoSOX fluorescence distributions obtained
by flow cytometry of MRC5 fibroblasts at PD46.4. The majority of
these cells at this PD were senescent. F) Senescent cell fraction
dynamics estimated from analysis of growth curves. Solid black
line is mean cell fraction estimate and dashed lines represent 95%
confidence range. Vertical blue lines represent PDs for model
calibration distributions (A,E). Vertical red lines represent PDs for
intermediate model validation distributions (B–D).
(PDF)
Figure 3. Mitochondrial ROS does not increase significantly
with population doublings following hTERT overexpression.
Mean MitoSOX fluorescence measured by flow cytometry at increasing
PDs in a purely proliferative population of MRC5 fibroblasts (blue
points), in the same population of cells undergoing transition to
senescence (light blue points), and in two independent experiments
using MRC5 fibroblasts immortalised by transfection with hTERT (green
points & purple points). Fluorescence in MRC5 fibroblasts is normalised
according to the value at PD27, as in Fig. 1B. All other datasets are
normalised according to the fluorescence levels at the earliest observed
PD.
doi:10.1371/journal.pone.0032117.g003
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